Patents Assigned to Golden Biotechnology Corporation
  • METHODS AND COMPOSITIONS FOR TREATING DIABETES
    Publication number: 20130172424
    Abstract: The present invention provides methods and compositions for treating diabetes by cyclohexenone compounds.
    Type: Application
    Filed: December 28, 2012
    Publication date: July 4, 2013
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventor: Golden Biotechnology Corporation
  • METHODS AND COMPOSITIONS FOR TREATING BRAIN CANCER
    Publication number: 20130158113
    Abstract: The present invention provides methods and compositions for treating brain cancer by cyclohexenone compounds.
    Type: Application
    Filed: June 7, 2012
    Publication date: June 20, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yung LIU, Wu-Che WEN
  • METHODS AND COMPOSITIONS FOR TREATMENT, MODIFICATION AND MANAGEMENT OF BONE CANCER PAIN
    Publication number: 20130142882
    Abstract: The present invention provides methods and compositions for treating, preventing, modifying (reducing), or managing bone cancer pain by cyclohexenone compounds.
    Type: Application
    Filed: November 14, 2012
    Publication date: June 6, 2013
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventor: GOLDEN BIOTECHNOLOGY CORPORATION
  • Inhibition of the Survival of Bladder Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20130005827
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bladder cancer cells and be used as a pharmaceutical composition to inhibit the bladder tumor growth.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20130005825
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of lymphoma cells and be used as a pharmaceutical composition to inhibit the lymphoma tumor growth.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Gastric Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20130005826
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of gastric cancer cells and be used as a pharmaceutical composition to inhibit the gastric tumor growth.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Bone Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20120322890
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bone cancer cells and be used as a pharmaceutical composition to inhibit the bone tumor growth.
    Type: Application
    Filed: August 28, 2012
    Publication date: December 20, 2012
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Methods and compositions for treating lung cancer
    Patent number: 8309611
    Abstract: The present invention provides methods and compositions for treating lung cancer by cyclohexenone compounds.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: November 13, 2012
    Assignee: Golden Biotechnology Corporation
    Inventors: Sheng-Yung Liu, San-Bao Hwang, Wu-Che Wen
  • INHIBITION OF THE SURVIVAL OF SKIN CANCER BY CYCLOHEXENONE COMPOUNDS FROM ANTRODIA CAMPHORATA
    Publication number: 20120277320
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of skin cancer cells and be used as a pharmaceutical composition to inhibit the skin tumor growth.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 1, 2012
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the survival of pancreatic cancer by cyclohexenone compounds from
    Patent number: 8236860
    Abstract: The present invention relates to a novel application of a compound. The compound 4--2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of pancreatic cancer cells and be used as a pharmaceutical composition to inhibit the pancreatic tumor growth.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: August 7, 2012
    Assignee: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • METHODS AND COMPOSITIONS FOR TREATING LUNG CANCER
    Publication number: 20120071426
    Abstract: The present invention provides methods and compositions for treating lung cancer by cyclohexenone compounds.
    Type: Application
    Filed: March 23, 2011
    Publication date: March 22, 2012
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yung Liu, San-Bao Hwang, Wu-Che Wen
  • Inhibition of the Survival of Colorectal Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110059123
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of colorectal cancer cells and be used as a pharmaceutical composition to inhibit the colorectal tumor growth.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Bladder Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110060059
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bladder cancer cells and be used as a pharmaceutical composition to inhibit the bladder tumor growth.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Gastric Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110060056
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of gastric cancer cells and be used as a pharmaceutical composition to inhibit the gastric tumor growth.
    Type: Application
    Filed: September 3, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110060055
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of lymphoma cells and be used as a pharmaceutical composition to inhibit the lymphoma tumor growth.
    Type: Application
    Filed: August 30, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Skin Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110060057
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3 -dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of skin cancer cells and be used as a pharmaceutical composition to inhibit the skin tumor growth.
    Type: Application
    Filed: September 3, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Ovarian Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110060058
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of ovarian cancer cells and be used as a pharmaceutical composition to inhibit the ovarian tumor growth.
    Type: Application
    Filed: September 3, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Oral Cavity Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110059122
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of oral cavity cancer cells and be used as a pharmaceutical composition to inhibit the oral cavity tumor growth.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Pancreatic Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110009494
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of pancreatic cancer cells and be used as a pharmaceutical composition to inhibit the pancreatic tumor growth.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Inhibition of the Survival of Bone Cancer by Cyclohexenone Compounds from Antrodia Camphorata
    Publication number: 20110009495
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bone cancer cells and be used as a pharmaceutical composition to inhibit the bone tumor growth.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo